| P50 | author | Carlos Pérez-Medina | Q59289478 |
| | Willem J.M. Mulder | Q62656505 |
| | Matthias Nahrendorf | Q88985829 |
| P2093 | author name string | Zahi A Fayad | |
| | Gert Storm | |
| | Josbert M Metselaar | |
| | Amr Alaarg | |
| P2860 | cites work | Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 |
| | Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species | Q22253929 |
| | VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. | Q40022029 |
| | Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion | Q40109796 |
| | Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop | Q40408955 |
| | [(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis | Q41029516 |
| | The IL23 axis plays a key role in the pathogenesis of IBD. | Q41111256 |
| | Cancer nanomedicine: Is targeting our target? | Q41169917 |
| | Contact-dependent stimulation of monocytic cells and neutrophils by stimulated human T-cell clones. | Q41353107 |
| | The codependence of angiogenesis and chronic inflammation | Q41508311 |
| | In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. | Q41534056 |
| | Angiotensin II mobilizes spleen monocytes to promote the development of abdominal aortic aneurysm in Apoe-/- mice | Q41669102 |
| | Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation | Q41838863 |
| | Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands | Q41851529 |
| | Image-guided drug delivery: preclinical applications and clinical translation. | Q42005331 |
| | Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. | Q42165286 |
| | Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide | Q42402124 |
| | Monocyte imaging after myocardial infarction with 19F MRI at 3 T: a pilot study in explanted porcine hearts. | Q42473587 |
| | Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation | Q42487126 |
| | Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. | Q43012179 |
| | Sensing caspase 3 activity with quantum dot-fluorescent protein assemblies | Q43130703 |
| | Angiotensin II drives the production of tumor-promoting macrophages | Q43239444 |
| | Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts | Q43800675 |
| | In vivo imaging of cell proliferation enables the detection of the extent of experimental rheumatoid arthritis by 3'-deoxy-3'-18f-fluorothymidine and small-animal PET. | Q43868385 |
| | Tumor regression by targeted gene delivery to the neovasculature | Q44044889 |
| | Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles | Q44616397 |
| | Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. | Q44775111 |
| | Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. | Q45370639 |
| | The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. | Q45992172 |
| | Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots | Q46208049 |
| | Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis | Q46220924 |
| | Liposomal prednisolone inhibits tumor growth in a spontaneous mouse mammary carcinoma model | Q46464566 |
| | Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics | Q46661181 |
| | Measuring intravascular migration of mouse Ly6C(low) monocytes in vivo using intravital microscopy | Q46765214 |
| | The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study | Q47856931 |
| | Intravascular ultrasound molecular imaging of atheroma components in vivo | Q47972229 |
| | MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor. | Q48544742 |
| | Bispecific antibodies for cancer therapy: the light at the end of the tunnel? | Q24644083 |
| | Identification of splenic reservoir monocytes and their deployment to inflammatory sites | Q24649151 |
| | Inflammation and cancer | Q24649640 |
| | Angiogenesis in the pathogenesis of inflammatory joint and lung diseases | Q24805418 |
| | Macrophages in rheumatoid arthritis | Q24806949 |
| | Challenges and strategies in anti-cancer nanomedicine development: An industry perspective | Q26748018 |
| | Targeting the CCL2-CCR2 signaling axis in cancer metastasis | Q26765184 |
| | The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis | Q26774681 |
| | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| | Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide | Q26783581 |
| | The role of macrophages and dendritic cells in the initiation of inflammation in IBD | Q26827408 |
| | Anti-inflammatory therapy in chronic disease: challenges and opportunities | Q26860162 |
| | Hematopoietic stem cell niche maintenance during homeostasis and regeneration | Q26865273 |
| | Imaging and nanomedicine in inflammatory atherosclerosis | Q27002916 |
| | Innate and adaptive immune cells in the tumor microenvironment | Q27008342 |
| | CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages | Q27308841 |
| | Elucidation of monocyte/macrophage dynamics and function by intravital imaging | Q27313900 |
| | Cancer-related inflammation | Q27860907 |
| | Immunity, Inflammation, and Cancer | Q27861048 |
| | Pattern recognition receptors and inflammation | Q27861115 |
| | Inflammation and cancer: back to Virchow? | Q28036756 |
| | Live cell imaging to understand monocyte, macrophage, and dendritic cell function in atherosclerosis | Q28071784 |
| | Vascular permeability--the essentials | Q28085112 |
| | Cholesterol, inflammation and innate immunity | Q28086912 |
| | Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications | Q28253399 |
| | Macrophages and their products in rheumatoid arthritis | Q28296955 |
| | Cytokines in the pathogenesis of rheumatoid arthritis | Q28303865 |
| | Monocytes link atherosclerosis and cancer | Q28390589 |
| | Immune cell screening of a nanoparticle library improves atherosclerosis therapy | Q28393434 |
| | Reactive oxygen species in inflammation and tissue injury | Q28396273 |
| | CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation | Q28506984 |
| | The Path to Personalized Medicine | Q29541502 |
| | Inflammation, atherosclerosis, and coronary artery disease | Q29547232 |
| | New targets for mucosal healing and therapy in inflammatory bowel diseases | Q35003977 |
| | Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. | Q35012766 |
| | Ischemic stroke activates hematopoietic bone marrow stem cells | Q35033609 |
| | Pattern recognition receptors: doubling up for the innate immune response | Q35036522 |
| | Nanoparticle imaging of integrins on tumor cells | Q35052180 |
| | Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation | Q35083309 |
| | Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1α activation: a novel aspect of angiogenesis in atherosclerosis | Q35101457 |
| | Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions | Q35121150 |
| | Regulation of vascular permeability by vascular endothelial growth factors. | Q35127972 |
| | Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis | Q35201491 |
| | Monocyte trafficking in acute and chronic inflammation | Q35230750 |
| | Therapeutic siRNA silencing in inflammatory monocytes in mice | Q35539710 |
| | 125I-labeled gold nanorods for targeted imaging of inflammation. | Q35569270 |
| | Adhesion molecules and atherosclerosis | Q35581561 |
| | Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells | Q35589891 |
| | Noninvasive imaging of immune responses | Q35616275 |
| | The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis | Q35630135 |
| | The fundamental basis of inflammatory bowel disease | Q35649436 |
| | Inflammatory bowel disease associated arthropathy | Q35680638 |
| | Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions | Q35687871 |
| | Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. | Q35764372 |
| | The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs | Q35904146 |
| | Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis | Q35936550 |
| | Peripheral and central effects of repeated social defeat stress: monocyte trafficking, microglial activation, and anxiety. | Q35954533 |
| | Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation | Q35964485 |
| | Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging | Q35995110 |
| | A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment | Q36021562 |
| | Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk. | Q36039489 |
| | Role of inflammatory mediators in angiogenesis. | Q36048112 |
| | Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis | Q36202794 |
| | Preventing chronic diseases: how many lives can we save? | Q36300585 |
| | Hypoxia regulates macrophage functions in inflammation. | Q36307141 |
| | Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome | Q36310475 |
| | Bone marrow angiogenesis in multiple myeloma | Q36343529 |
| | Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer | Q49159932 |
| | Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches. | Q50438830 |
| | Angiogenesis in the bone marrow of patients with breast cancer. | Q50759831 |
| | Selective uptake of surface-modified phospholipid vesicles by bone marrow macrophages in vivo. | Q51062527 |
| | Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro. | Q51097436 |
| | Detection of Cancer-Specific Proteases Using Magnetic Relaxation of Peptide-Conjugated Nanoparticles in Biological Environment. | Q51319222 |
| | Liposome-Loaded Cell Backpacks. | Q51625765 |
| | Tumor-associated macrophages press the angiogenic switch in breast cancer. | Q51984236 |
| | PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis. | Q53083524 |
| | Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. | Q53249650 |
| | Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study. | Q53254775 |
| | Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappaB activation. | Q54344637 |
| | Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. | Q55049410 |
| | Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging | Q57188260 |
| | Assessing permeability alterations of the blood-bone marrow barrier due to total body irradiation: in vivo quantification with contrast enhanced magnetic resonance imaging | Q57188857 |
| | Synthesis and evaluation of new NIR-fluorescent probes for cathepsin B: ICT versus FRET as a turn-ON mode-of-action | Q57617338 |
| | Tc-99m-PEG-Liposomes for the evaluation of colitis in Crohn's disease | Q57779775 |
| | A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors | Q58450373 |
| | Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo | Q58816167 |
| | Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models | Q62100948 |
| | The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow | Q68213213 |
| | Synovial tissue macrophage populations and articular damage in rheumatoid arthritis | Q70859981 |
| | An immunohistochemical and immunoelectron microscopic study of adhesion molecules in synovial pannus formation in rheumatoid arthritis | Q71645430 |
| | Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture | Q72034135 |
| | Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis | Q73028001 |
| | Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis | Q73069483 |
| | Role of bone marrow-derived cells in tumor angiogenesis and treatment | Q73614629 |
| | Angiogenesis in rheumatoid arthritis | Q74443495 |
| | Imaging experimental osteomyelitis using radiolabeled liposomes | Q74650110 |
| | Cancer and atherosclerosis: the broad mandate of angiogenesis | Q77222227 |
| | Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease | Q77904655 |
| | p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease | Q78058025 |
| | Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis | Q79851922 |
| | Matrix metalloproteinases and angiogenesis | Q81864212 |
| | Leaky effect | Q83382441 |
| | Bone marrow angiogenesis and progression in multiple myeloma | Q83699933 |
| | New basic care goals seek to rein in global rise in cardiovascular disease | Q85335088 |
| | Immunology. Neutrophil-macrophage communication in inflammation and atherosclerosis | Q85620351 |
| | Osteoimmunology in 2014: Two-faced immunology-from osteogenesis to bone resorption | Q86478868 |
| | Cancer nanomedicines: closing the translational gap | Q86607263 |
| | Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer | Q86619896 |
| | Metabolic activity of the spleen and bone marrow in patients with acute myocardial infarction evaluated by 18f-fluorodeoxyglucose positron emission tomograpic imaging | Q87218257 |
| | Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles | Q34079604 |
| | The immune system in atherosclerosis | Q34164644 |
| | Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases | Q34181228 |
| | Network dynamics determine the autocrine and paracrine signaling functions of TNF. | Q34271348 |
| | Macrophages in atherosclerosis: a dynamic balance. | Q34368005 |
| | Regulation and consequences of monocytosis | Q34372534 |
| | Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease | Q34377789 |
| | Imaging macrophages with nanoparticles | Q34399530 |
| | Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer | Q34426754 |
| | Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities | Q34479597 |
| | Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease | Q34523071 |
| | Neovascularization in human atherosclerosis | Q34523545 |
| | Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. | Q34531618 |
| | Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas | Q34569613 |
| | Fluorine (19F) MRS and MRI in biomedicine | Q34635770 |
| | Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes | Q34650719 |
| | Abandoning M1/M2 for a Network Model of Macrophage Function | Q34677978 |
| | Vascular permeability, vascular hyperpermeability and angiogenesis | Q34753662 |
| | Seven challenges for nanomedicine | Q34800745 |
| | Toll-like receptors as potential therapeutic targets for multiple diseases | Q34932177 |
| | Personalizing health care: feasibility and future implications | Q34938911 |
| | Unravelling the pathogenesis of inflammatory bowel disease | Q29547551 |
| | Macrophage plasticity and polarization: in vivo veritas | Q29547620 |
| | Origin and physiological roles of inflammation | Q29614298 |
| | Angiogenesis: an organizing principle for drug discovery? | Q29614538 |
| | NF-kappaB: linking inflammation and immunity to cancer development and progression | Q29614597 |
| | The pathogenesis of rheumatoid arthritis | Q29614957 |
| | Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators | Q29615694 |
| | NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 |
| | The M1 and M2 paradigm of macrophage activation: time for reassessment | Q29615845 |
| | Macrophage diversity enhances tumor progression and metastasis | Q29615847 |
| | Genetics and pathogenesis of inflammatory bowel disease | Q29616350 |
| | Collective cell migration in morphogenesis, regeneration and cancer | Q29616634 |
| | Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors | Q29617042 |
| | Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 |
| | The many roles of chemokines and chemokine receptors in inflammation | Q29618880 |
| | Matrix metalloproteinases: regulators of the tumor microenvironment | Q29619858 |
| | Inflammation meets cancer, with NF-κB as the matchmaker | Q29620242 |
| | Macrophage biology in development, homeostasis and disease | Q29620350 |
| | Protective and pathogenic functions of macrophage subsets | Q29620351 |
| | Nanoparticles for imaging: top or flop? | Q30429119 |
| | Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. | Q30432690 |
| | Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound | Q30454160 |
| | Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions | Q30488574 |
| | Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging | Q30490862 |
| | Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions | Q30543404 |
| | Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation. | Q30574501 |
| | The process of macrophage migration promotes matrix metalloproteinase-independent invasion by tumor cells | Q30611389 |
| | Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle | Q31141702 |
| | Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. | Q33292668 |
| | A combinatorial library of lipid-like materials for delivery of RNAi therapeutics | Q33330928 |
| | Monocyte scintigraphy in rheumatoid arthritis: the dynamics of monocyte migration in immune-mediated inflammatory disease | Q33516229 |
| | Cancer nanomedicines: oversold or underappreciated? | Q33602272 |
| | Innate and adaptive immunity in atherosclerosis | Q33659705 |
| | Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases | Q33733160 |
| | The key role of macrophages in the immunopathogenesis of inflammatory bowel disease | Q33853551 |
| | Atherosclerosis in ancient Egyptian mummies: the Horus study. | Q33863379 |
| | Chronic variable stress activates hematopoietic stem cells | Q33864613 |
| | Engineered nanomedicine for myeloma and bone microenvironment targeting. | Q33926003 |
| | Anatomical basis of tolerance and immunity to intestinal antigens | Q33965210 |
| | Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation | Q34028645 |
| | Tumor angiogenesis phenotyping by nanoparticle-facilitated magnetic resonance and near-infrared fluorescence molecular imaging. | Q36343788 |
| | Cells of the synovium in rheumatoid arthritis. Macrophages | Q36465497 |
| | Scavenger receptors in atherosclerosis: beyond lipid uptake | Q36489900 |
| | Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function | Q36497982 |
| | PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles | Q36533549 |
| | TNFalpha blockade in human diseases: mechanisms and future directions | Q36536886 |
| | Heat-Induced Radiolabeling of Nanoparticles for Monocyte Tracking by PET. | Q36581653 |
| | Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression | Q36594764 |
| | Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach | Q36612202 |
| | The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease | Q36745053 |
| | Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors | Q36775202 |
| | Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy | Q36804366 |
| | Cancer and Its Association With the Development of Coronary Artery Calcification: An Assessment From the Multi-Ethnic Study of Atherosclerosis | Q36836294 |
| | Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal | Q36944727 |
| | Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging | Q36948874 |
| | Innate immunity in inflammatory bowel disease. | Q36975932 |
| | Macrophages and chemokines as mediators of angiogenesis | Q36983319 |
| | Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. | Q37024507 |
| | Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation. | Q37081749 |
| | Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis | Q37085672 |
| | Local proliferation dominates lesional macrophage accumulation in atherosclerosis | Q37161176 |
| | Principles of nanoparticle design for overcoming biological barriers to drug delivery | Q37162182 |
| | Tube travel: the role of proteases in individual and collective cancer cell invasion | Q37270069 |
| | Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice | Q37326948 |
| | Protease-triggered unveiling of bioactive nanoparticles | Q37381733 |
| | Reactive oxygen species in cancer | Q37431048 |
| | RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction. | Q37445494 |
| | Biomimetic proteolipid vesicles for targeting inflamed tissues | Q37451394 |
| | Tracking immune cells in vivo using magnetic resonance imaging | Q37455363 |
| | A monoclonal antibody against alphaVbeta3 integrin inhibits development of atherosclerotic lesions in diabetic pigs | Q37609369 |
| | Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes | Q37627094 |
| | Inflammation in atherosclerosis: transition from theory to practice | Q37672113 |
| | A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation | Q37727091 |
| | Diverse Applications of Nanomedicine | Q37728142 |
| | The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights | Q37732574 |
| | Therapeutic antibodies for autoimmunity and inflammation | Q37736260 |
| | Innate immunity and rheumatoid arthritis | Q37761419 |
| | State-of-the-art: rheumatoid arthritis | Q37801492 |
| | Nanomedicine. | Q37821004 |
| | Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage | Q37845554 |
| | Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets | Q37866627 |
| | Extracellular proteolysis in macrophage migration: losing grip for a breakthrough | Q37939732 |
| | Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability | Q37951920 |
| | Drug targeting systems for inflammatory disease: one for all, all for one. | Q37973956 |
| | Hypoxia: how does the monocyte-macrophage system respond to changes in oxygen availability? | Q38156255 |
| | Cancer nanomedicine: from drug delivery to imaging | Q38172476 |
| | From proliferation to proliferation: monocyte lineage comes full circle | Q38179249 |
| | Liposomal corticosteroids for the treatment of inflammatory disorders and cancer | Q38216097 |
| | Tumor-associated macrophages: from mechanisms to therapy | Q38230880 |
| | Alternative pathways of osteoclastogenesis in inflammatory arthritis | Q38271156 |
| | In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. | Q38468041 |
| | Toward a Better Understanding of the Complexity of Cancer Drug Resistance | Q38619427 |
| | Ontogeny of Tumor-associated Macrophages and Its Implication in Cancer Regulation | Q38763465 |
| | Lipid-based nanocarriers for oral peptide delivery. | Q38808878 |
| | Angiogenesis regulation by nanocarriers bearing RNA interference | Q38978187 |
| | Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release | Q39016817 |
| | Tumor-homing glycol chitosan-based optical/PET dual imaging nanoprobe for cancer diagnosis | Q39026131 |
| | Non-invasive optical imaging of cathepsin B with activatable fluorogenic nanoprobes in various metastatic models | Q39041342 |
| | Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans. | Q39061766 |
| | Cytokines in inflammatory bowel disease | Q39206254 |
| | Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice | Q39649085 |
| | Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis | Q39701973 |
| | Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. | Q39758196 |
| | Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. | Q39903564 |
| | Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice | Q39964878 |
| | Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model | Q39979176 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanomedicine | Q261659 |
| P304 | page(s) | 143-158 | |
| P577 | publication date | 2017-05-12 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Applying nanomedicine in maladaptive inflammation and angiogenesis | |
| P478 | volume | 119 | |